RFA
WST icon

Resurgent Financial Advisors’s West Pharmaceutical WST Stock Holding History

Resurgent Financial Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-58
Closed -$22.2K – 532
2023
Q2 		$22.2K Sell
58
-1
-2% -$357 0.01% 485
2023
Q1 		$20.4K Sell
59
-30
-34% -$8.77K 0.01% 479
2022
Q4 		$20.9K Buy
+89
New +$21.1K 0.01% 612

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Resurgent Financial Advisors's WST Position: Q3 2023 in Review

Resurgent Financial Advisors sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 58 shares — an estimated $22.2K sold.

Resurgent Financial Advisors first reported a position in WST in Q4 2022 and held it in 3 quarters. The position peaked at $22.2K in Q2 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Resurgent Financial Advisors reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Resurgent Financial Advisors sold 58 West Pharmaceutical shares in Q3 2023, an estimated $22.2K.
  • Resurgent Financial Advisors first reported a position in West Pharmaceutical in Q4 2022 and held it in 3 quarters.
  • Resurgent Financial Advisors's West Pharmaceutical position peaked at $22.2K in Q2 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Resurgent Financial Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.